Merck & Co (NYSE: MRK)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $128.66
-
Support level$121.40
-
Resistance levelN/A
-
Beta0.2
-
RSI (14-day)65.0
- MRK is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- Up 13.0 percent, MRK is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
- Price crossed above 50-day moving average this week - a bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $77.60 | $128.66 | 100.0% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $106.33 | $115.84 | $118.62 | $118.82 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week9.2%
-
In the next month14.0%
-
In the next year55.1%
| Period | Value |
|---|---|
| Historical (5 year) | 23.8% |
| Last month | 22.7% |
| Current estimate | 34.0% |
| Next month forecast | 24.7% |